Track:
QUALITY ASSURANCE AND QUALITY CONTROL OF PRODUCTS
Sessions & Session Descriptions:
Evolution and Development of Cannabis-based Products
Significant changes in federal regulations concerning research on cannabis and the development of cannabis-based therapies have occurred over the last twelve years. Prior to that, federal controlled substance regulations classified all forms of cannabis materials as DEA Schedule-I materials that required a DEA registration to acquire and possess. Over the same time state-sanctioned medical and adult-use programs caused a proliferation of extensive varieties of cannabis-based products that were restricted to use within each state’s system. Although hemp production was allowed under certain condition by the 2014 Farm Bill, it was the 2018 Farm Bill that dramatically accelerated the production of hemp-based products intended to benefit human health. Many lawmakers, consumers, medical professionals, and researchers are now confused on the composition and quality of the multitude of cannabis-based products and synthetic cannabinoids that are readily available in various markets. This session will explore how cannabis products have developed to coincide with the evolution of both state-sanctioned medical cannabis programs and the implementation of the 2018 Farm Bill. Presenters will offer practical information regarding medical cannabis products, hemp-derived commercial products, FDA-approved products, research materials, and unregulated products. Discussions will include aspects of production and distribution of plant-based materials as well as isolated or synthesized cannabinoids. Stability data of certain products will be presented, as well.
The Necessity of Laboratory Certification
Our comprehensive session will delve into the importance of laboratory certification, highlighting the numerous benefits it brings to operating laboratories in the cannabis industry. The presentation will provide an in-depth outline of the laboratory certification process through the Colorado Department of Public Health and Environment's (CDPHE) Cannabis and Natural Medicine program, as well as offer real-world examples and case studies to illustrate the practical applications of certification. Furthermore, we will discuss the primary goals of certification, including the critical need for standardized laboratory results and data defensibility - a significant issue that has plagued the cannabis industry due to variations in testing methods and protocols. Specifically, CDPHE hemp certification aims to align laboratory results as closely as possible, ensuring accuracy, reliability, and consistency across different laboratories. We will also examine our state's specific requirements for testing and certification, exploring the historical context and regulatory framework that led to the development of these rules. By understanding the evolution of these regulations, attendees will gain valuable insights into the complexities of the industry and the role that laboratory certification plays in ensuring public safety and promoting consumer confidence. Additionally, we will explore how laboratories can navigate the certification process, overcome common challenges, and maintain compliance with state regulations.